Big business asked for deregulation; Morneau delivered in spades

Earlier this year, the Chamber of Commerce released yet another report on how public protections and other regulatory requirements are undermining Canadian competitiveness—and how the government should go about deregulating to make life easier for businesses big and small. Though it wasn’t directly tied to the Trump administration’s massive gutting…
Read more

The New NAFTA – What’s the Deal with Energy?

In the aftermath of the USMCA negotiations, the Trudeau government chalked up two significant “wins” for environmental protection and Canadian sovereignty: the elimination of investor state dispute settlement (ISDS), at least in the Canada-U.S. context, and the disappearance of NAFTA’s so-called proportionality clause in the energy chapter. The latter is…
Read more

Ontario Economic Update: Financial fearmongering act II

Ontario’s economic update, released today, is Act II of a financial fearmongering stunt. Act I was the line-by-line review that contends public expenditures have grown by an exorbitant 55 per cent over the past 15 years. We analyzed the out-of-context figures and coded language and described it as a frame…
Read more

Why high U.S. drug prices matter to Canada

In the mid-1970s the average monthly cost of a cancer drug in the United States was about $100. By 1995 that cost had crept up to about $1,800 per month and today it is over $10,000. Similarly, while drugs for multiple sclerosis introduced in the mid-1990s cost about $8,000 per…
Read more

The house that debt built

In a speech in May, Bank of Canada Governor Stephen Poloz told a scary story about household debt. No matter how you measure it—as a share of disposable income (170%, a Canadian record), as a share of Canada’s GDP (100%, one of the highest factors in the world)—things look pretty…
Read more